A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Add-On to Standard Of-Care Study of n Butylphthalide (NBP) Softgel Capsules for Treatment of Mild to Moderate Acute Ischemic Stroke (AIS) in Adult Subjects
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Butylphthalide (Primary)
- Indications Stroke
- Focus Adverse reactions
- Sponsors CSPC-NBP Pharmaceutical
- 16 Sep 2020 Status changed from recruiting to completed.
- 11 May 2020 Status changed from active, no longer recruiting to recruiting.
- 29 Apr 2020 Planned End Date changed from 1 Nov 2020 to 1 Jan 2021.